Post-transplant Lymphoproliferative Disorder (PTLD): Infection, Cancer?

被引：0
|
作者：
Voorhees T.J. [1 ]
Baiocchi R.A. [1 ,2 ]
机构：
[1] Department of Internal Medicine, Division of Hematology, Ohio State University College of Medicine, 460 West 10th Avenue, Columbus, 43210, OH
[2] Division of Hematology, The Ohio State University, 320 West 10th Avenue, Columbus, 43210, OH
来源：
Current Transplantation Reports | 2016年 / 3卷 / 2期
关键词：
EBV; EBV oncogenesis; EBV transformation; Post-transplant lymphoproliferative disorder;
D O I：
10.1007/s40472-016-0102-0
中图分类号：
学科分类号：
摘要：
Post-transplant lymphoproliferative disorder encompasses a broad spectrum of lymphoid disorders that occur in immune-suppressed patients following solid or hematopoietic stem cell transplantation. The Epstein-Barr virus (EBV) is an oncogenic virus capable of transforming B lymphocytes and is associated with the pathogenesis of multiple benign and malignant lymphoproliferative disorders, including PTLD. This review outlines current knowledge of EBV pathogenesis, its role in B cell immortalization, transformation, and as an etiologic agent in lymphoproliferative disorders in immune-suppressed patients following transplantation. Here, we provide discussion incorporating infectious disease and medical oncology aspects. © 2016, Springer International Publishing AG.
引用
收藏
页码：145 / 153
页数：8
相关论文
共 50 条
  • [41] Improved Survival with Recent Post-Transplant Lymphoproliferative Disorder (PTLD) in Children with Kidney Transplants
    Dharnidharka, V. R.
    Martz, K. L.
    Stablein, D. M.
    Benfield, M. R.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2011, 11 (04) : 751 - 758
  • [42] Hepatitis C virus (HCV) infection and risk of post-transplant lymphoproliferative disorder (PTLD) after liver transplantation
    Morton, Lindsay M.
    Landgren, Ola
    Chatterjee, Nilanjan
    Castenson, David
    Parsons, Ruth
    Hoover, Robert N.
    Engels, Eric A.
    CANCER RESEARCH, 2006, 66 (08)
  • [43] TREATMENT OF POST-TRANSPLANT LYMPHOPROLIFERATIVE DISORDER (PTLD): A MULTI-CENTER PEDIATRIC SERIES
    Marks, Lianna
    Green, Michael
    Storch, Gregory
    Gratzinger, Dita
    Gu, Hongjie
    Goss, Charles
    Dharnidharka, Vikas
    PEDIATRIC BLOOD & CANCER, 2022, 69
  • [44] Post-transplant lymphoproliferative disorder (PTLD) patients treated with high-dose methotrexate
    Nabors, Louis
    Julian, Bruce
    Kew, Clifton
    Palmer, Cheryl
    NEURO-ONCOLOGY, 2007, 9 (04) : 521 - 521
  • [45] Current Trends in Post-Transplant Lymphoproliferative Disorder (PTLD): A Hospital-Based Registry
    Barton, Michelle
    Dipchand, Anne
    Hebert, Diane
    Ng, Vicky
    Solomon, Melinda
    Fecteau, Annie
    Grant, David
    Ngan, Bo
    Weitzman, Sheila
    Allen, Upton
    AMERICAN JOURNAL OF TRANSPLANTATION, 2009, 9 : 458 - 458
  • [46] MORTALITY OUTCOMES OF POST-TRANSPLANT LYMPHOPROLIFERATIVE DISORDER (PTLD) ACCORDING TO DISEASE SITES AT PRESENTATION
    Allen, U.
    Dipchand, A.
    Ng, V.
    Hebert, D.
    Avitzur, Y.
    Solomon, M.
    PEDIATRIC TRANSPLANTATION, 2015, 19 : 93 - 93
  • [47] Differing Characteristics of Early and Late Post-Transplant Lymphoproliferative Disorder (PTLD) in Kidney Recipients
    Bloom, J. H.
    Tsai, K. J.
    Rashef, R.
    Sawinski, D.
    Bleicher, M.
    Goral, S.
    Trofe-Clark, J.
    Bloom, R. D.
    Tsai, D. E.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2012, 12 : 155 - 156
  • [48] Kidney Re-Transplantation (reTx) in Patients with Post-Transplant Lymphoproliferative Disorder (PTLD).
    Lankireddy, S.
    Kukla, A.
    Ibrahim, H.
    Matas, A.
    Issa, N.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2013, 13 : 472 - 472
  • [49] Gene polymorphism associated with early-onset post-transplant lymphoproliferative disorder (PTLD).
    VanBuskirk, AM
    Malik, V
    Xia, DY
    Pelletier, RP
    TRANSPLANTATION, 2000, 69 (08) : S392 - S393
  • [50] The use of FDG-PET/CT in pediatric post-transplant lymphoproliferative disorder (PTLD)
    Gillman, Jennifer
    Servaes, Sabah
    States, Lisa
    JOURNAL OF NUCLEAR MEDICINE, 2020, 61
12345